男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

China approves mRNA COVID-19 vaccine for emergency use

By WANG XIAOYU | chinadaily.com.cn | Updated: 2023-03-22 17:25
Share
Share - WeChat
FILE PHOTO: A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken on April 10, 2020. [Photo/Agencies]

Domestic drugmaker CSPC Pharmaceutical Group said on Wednesday that its COVID-19 vaccine based on the messenger RNA technology has gained emergency use authorization from China's top drug regulator.

The vaccine, named SYS6006, is designed to target the BA.5 variant of Omicron, the company said in a statement released on its official website. It is the first mRNA vaccine to be approved for use in China.

The drug was approved for clinical trials in April last year. So far, it has gone through the first two trial phases, and research on its effectiveness as a booster shot has been completed.

Trials involving over 5,500 participants have affirmed its safety, immunogenicity and protective effects, the company said.

The incidence rate and severity of adverse reactions among senior participants was much lower than that among younger ones, it added.

When a dose of SYS6006 was delivered as a booster shot to people who had been vaccinated with two or three doses of inactivated vaccines, it demonstrated good protective effects against multiple variants, including BA.5, BF.7, BQ.1.1, XBB.1.5 and CH.1.1.

Research data also show that the vaccine can induce T cell memory response against different variants, including Delta and the BA.2 and BA.5 Omicron variants.

The product should be stored at temperatures between 2 and 8 degrees Celsius.

By the end of last year, China had granted conditional market approval to five COVID-19 vaccines and emergency use approval to eight vaccines.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 宜都市| 会同县| 罗城| 玛多县| 北安市| 肇州县| 濉溪县| 兰考县| 五家渠市| 肥东县| 宁阳县| 泸溪县| 丽江市| 大化| 同心县| 尼玛县| 景泰县| 屯留县| 临颍县| 沭阳县| 嘉荫县| 尼木县| 磐安县| 岢岚县| 奇台县| 潜江市| 阜宁县| 迁西县| 离岛区| 金乡县| 东海县| 巴楚县| 弋阳县| 崇明县| 贵德县| 宝丰县| 清涧县| 南城县| 博乐市| 肇东市| 清远市|